Proven
neurotechnology
built for the
real world
Control Bionics delivers objective, non-invasive neural-signal technology, proven in clinical environments, and built to scale across performance, rehabilitation, medical, research, and assistive communication.
Proven
neurotechnology
built for the
real world
Control Bionics delivers objective, non-invasive neural-signal technology, proven in clinical environments, and built to scale across performance, rehabilitation, medical, research, and assistive communication.
Capability
From signal to actionable insight
The Control Bionics neural-signal platform captures physiological data with medical-grade precision and converts it into measurable, decision-ready outcomes. Built for deployment across clinical, research, and performance environments — and validated where it counts.
Signal acquisition and processing
Real-time analysis and validation
Clinical integration and reporting
Technology
The platform serves distinct markets with precision and measurable outcomes. One underlying technology - four applications.
A platform built for clinical deployment
Medical-grade signal processing meets real-world clinical environments. Designed for integration, validation, and measurable outcomes.
Non-invasive neural signal capture
Physiological data without surgical intervention or implantation. Validated for use in complex clinical environments.
Regulatory pathway established
Cleared for clinical use with ongoing validation across multiple applications — FDA, TGA, and CE registered.
Outcome-focused architecture
Platform designed to deliver decision-ready insights, not only raw data. Built to integrate into clinical and research workflows.
Evidence from clinical and research deployment
Control Bionics technology is validated through research, clinical trials, and real-world deployment across rehabilitation, performance, and research settings.
1,000s of users
Trusted by individuals, clinicians, and organisations across four markets
Government and privately funded
Approved for funding through Medicare, Medicaid, NDIS, and private insurance pathways.
100%
Non-invasive signal acquisition
3 Regulatory clearances
(FDA, TGA, CE)
Latest from our platform
Research, clinical validation and platform developments.
Giving Voice to Kids and Their Families: Meet Ian
Meet Ian. He’s learning language and communicating with his family using the NeuroNode Trilogy.
Control Bionics Named one of Top Medtech Providers 2021
This year, Control Bionics was honored to be included in the annual listing of 20 companies that are at the forefront of providing Medtech Year End Special Solutions and impacting the industry.
Powerful Update: Grid 3 Released 2 New WordPower 100 Versions
Belva Holman, B.A. Ed., ATP/ATACP and consultant at Control Bionics worked closely with Nancy Inman, M.A.T., CCC-SLP and creator of Inman Innovations, during Nancy’s development of a new robust and intuitive version of WordPower 100.
Bulls N’ Bears: Control Bionics CEO Rob Wong talks to host Matt Birney
This week, Control Bionics CEO Rob Wong sat down with Bulls N’ Bears host Matt Birney to discuss the company’s innovative technology and market growth. Listen to the full interview.
Select your path to neural-signal insights and outcomes
Explore how the platform integrates into clinical workflows and delivers decision-ready outcomes.
Learn more
Discover how researchers are using real-time neural data to power breakthrough studies.
LearnNDIS-registered provider
Control Bionics is a registered NDIS provider. Eligible participants can access our assistive communication devices and neurotechnology solutions through their NDIS plan.